updates from a phase ii study of bomedemstat for the treatment of essential thrombocythemia
Published 1 year ago • 956 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
2:24
update on phase iib study of bomedemstat in essential thrombocythemia
-
5:40
results of phase ii study of bomedemstat in myelofibrosis
-
0:46
a phase ii study of the lsd1 inhibitor bomedemstat in patients with polycythemia vera
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
7:42
phase ii trial of bomedemstat for advanced myelofibrosis
-
1:03
most: an observational study of myelofibrosis and essential thrombocythemia
-
3:21
the current standard of care for patients with essential thrombocythemia
-
1:25
exciting updates in essential thrombocythemia: exploring novel agents
-
3:53
essential thrombocythemia watch & wait | what patients should know
-
12:06
can patients with polycythemia vera (pv) live a normal lifespan?
-
4:14
iavi annual report 2022
-
3:05
updates on the phase i study of ft-4202 for scd
-
1:49
mechanism of action of bomedemstat
-
1:47
bomedemstat normalizes platelet count for essential thrombocythemia
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
3:06
the unmet needs of essential thrombocythemia and polycythemia vera patients
-
1:39
upcoming agents in et and pv
-
1:42
unmet needs in the polycythemia vera and essential thrombocythemia
-
2:54
unmet needs in myelofibrosis and future outlooks
-
3:29
unmet needs and therapeutic strategies in essential thrombocythemia
-
1:57
surpass et: p1101 in essential thrombocythemia
-
3:22
updates from a phase i study evaluating dendritic cell therapy, cryosurgery & pembrolizumab in nhl